Westfield Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Westfield Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-993,942	Closed	-$79.3M	–	257
2022 Q2	$79.3M	Buy	993,942 +84,113	+9%	+$7.97M	0.62%	49
2022 Q1	$95.7M	Buy	909,829 +198,015	+28%	+$19.3M	0.61%	51
2021 Q4	$76.7M	Buy	+711,814	New	+$77.7M	0.46%	75
2021 Q3	–	Sell	-293,016	Closed	-$27.4M	–	264
2021 Q2	$27.4M	Sell	293,016 -357,048	-55%	-$32.9M	0.16%	165
2021 Q1	$59.8M	Sell	650,064 -156,124	-19%	-$13.2M	0.37%	101
2020 Q4	$59M	Buy	+806,188	New	+$59.9M	0.35%	103

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Westfield Capital Management's HZNP Position: Q3 2022 in Review

Westfield Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 993,942 shares — an estimated $79.3M sold.

Westfield Capital Management first reported a position in HZNP in Q4 2020 and held it in 6 quarters. The position peaked at $95.7M in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Westfield Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Westfield Capital Management sold 993,942 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $79.3M.
Westfield Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 6 quarters.
Westfield Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $95.7M in Q1 2022.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Westfield Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.